Mm. Ibrahim et al., Allodynia and hyperalgesia produced by specific inhibition of spinal c-fosexpression: Lack of correlation with dynorphin content, J PAIN, 2(4), 2001, pp. 241-249
Inhibition of spinal Fos expression increases formalin-induced nociception
and decreases spinal prodynorphin messenger ribonucleic acid (mRNA), sugges
ting that Fos modulates nociception by inducing dynorphin synthesis. This s
tudy tests the hypothesis that Fos modulates sensitivity to other somatic s
timuli, such that inhibition of Fos expression will result in tactile allod
ynia and thermal hyperalgesia. In addition, it correlates the somatosensory
effects of inhibition of Fos expression with spinal dynorphin content. Ant
isense oligodeoxynucleotide (ODN) to c-fos mRNA was administered by intrath
ecal infusion. Tactile sensitivity was tested by probing the hindpaw with v
on Frey filaments. Thermal sensitivity was quantitated by using withdrawal
latency to radiant heat. Two percent formalin was injected into the dorsal
hindpaw, and flinches were quantitated. Fos was quantitated by counting imm
unoreactive cells. Dynorphin was measured by immunoassay. Intrathecal antis
ense, but not mismatch, ODN resulted in tactile allodynia, thermal hyperalg
esia, and hyperalgesia to formalin-induced nociception. Antisense ODN decre
ased Fos-like immunoreactivity after formalin injection but did not alter J
un-like immunoreactivity. Antisense ODN had differing effects on spinal dyn
orphin content, depending an the method of administration. These experiment
s show a role of Fos in modulating somatosensory sensitivity and suggest th
at induction of dynorphin synthesis is not the sole mechanism by which Fos
does so. (C) 2001 by the American Pain Society.